Related Experiment Videos
Pancreatitis induced by mesalamine
F Erdkamp1, M Houben, E Ackerman
1Department of Internal Medicine, Catharina Hospital, Eindhoven, Netherlands.
The Netherlands Journal of Medicine
|August 1, 1992
Abstract:
Sulphasalazine is an active agent in the treatment of chronic inflammatory bowel disease, but there are a number of well-known side effects, including pancreatitis. The newer 5-ASA agents are thought to be equally effective but less toxic. Here we describe a patient who developed a pancreatitis due to mesalamine; this was confirmed at rechallenge.